Latest database descriptions

To collect health data about conditions workers and covid-19 serology status in Orleans Metropole, Loiret District and the Centre Val de Loire Region

Based on the collection of capillary blood samples taken by the subjects, SAPRIS-SERO will help to:
• Estimate the cumulative incidence of infection in the general population (objective 1a),
• Characterise the “immune” portion of the population and the durability of immunity (objective 1b).

Primary objective : Describe in current medical practice the evolution of hemoglobin levels during the 9-month follow-up in each subgroup defined by the Charlson comorbidity index.

Secondary objectives :
- Describe the characteristics of patients treated with Mircera® in the total population and in the subgroups defined by the Charlson comorbidity index;
- Describe the evolution of the hemoglobin level during the observation period according to the Liu comorbidity index and to ESA resistance factors;
- Describe the changes in the Mircera® dosage during the observation period in the total population and in the subgroups defined by the Charlson comorbidity index;
- Describe the safety profile of Mircera® during the observation period in the total population and in the subgroups defined by the Charlson comorbidity index.

The main objective of this study is to describe the natural course of vascular Ehlers-Danlos syndrome, in particular the order of appearance of different types of complications (arterial, digestive, pulmonary and uterine).